Latest / PETRI DISH PERSPECTIVES
Episode 71: Fate of Pharma M&A
Send us Fan Mail
In this episode of Petri Dish Perspectives, we take a step back from individual companies to examine one of the most powerful forces shaping the pharmaceutical industry: M&A, licensing, and the global competition for innovation.
We explore how today's pharmaceutical giants were built through decades of consolidation, from Pfizer, GlaxoSmithKline, and Novartis to some of the industry's biggest modern transactions and why dealmaking has increasingly become essential for companies facing massive patent cliffs. But modern pharma is changing. Instead of relying solely on internal…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.